Brief: HLS Says Vascepa Is Now Reimbursed By Ontario's Provincial Drug Plan
July 25 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS ANNOUNCES THAT VASCEPA® IS NOW REIMBURSED BY ONTARIO'S
PROVINCIAL DRUG PLAN
* HLS THERAPEUTICS INC - PLA WITH ONTARIO IS EFFECTIVE JULY
21,
2022
Source text for Eikon: ID:nCNWd5HyWa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group